Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Dec;13(5-6):556-61.
doi: 10.1016/j.cbpa.2009.09.015. Epub 2009 Oct 14.

Non-genetic cell-to-cell variability and the consequences for pharmacology

Affiliations
Review

Non-genetic cell-to-cell variability and the consequences for pharmacology

Mario Niepel et al. Curr Opin Chem Biol. 2009 Dec.

Abstract

Recent advances in single-cell assays have focused attention on the fact that even members of a genetically identical group of cells or organisms in identical environments can exhibit variability in drug sensitivity, cellular response, and phenotype. Underlying much of this variability is stochasticity in gene expression, which can produce unique proteomes even in genetically identical cells. Here we discuss the consequences of non-genetic cell-to-cell variability in the cellular response to drugs and its potential impact for the treatment of human disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Cell-to-cell variability of the proteome gives rise to phenotypic heterogeneity
(a) Interaction among factors that determine average cellular phenotype and variance around the average. Combinations of environmental (blue), genomic (red) and proteomic (green) variation can cause heterogeneity in an initially homogenous population. (b) Probability density functions of three lognormal distributions with different coefficients of variation (CV; standard deviation divided by the mean). Red bars show the increasing disparity in protein levels between cells in the bottom and the top 5th percentiles. Protein numbers for the top and bottom 5th percentile and their ratio are shown for each distribution, assuming a mean of 100,000 proteins per cell. (c) Three hypothetical cases illustrating how the mean phenotype of a population (top row) can arise from different underlying phenotypic distributions (bottom row) at the single cell level. (d) Illustration of the effects of various transfer functions linking protein levels to phenotypes. The histograms (red) represent the distribution of phenotypes in a population generated by applying the univariate transfer functions (blue) to the protein level probability density functions (green).

References

    1. Albeck JG, Burke JM, Aldridge BB, Zhang M, Lauffenburger DA, Sorger PK. Quantitative analysis of pathways controlling extrinsic apoptosis in single cells. Mol Cell. 2008;30:11–25. - PMC - PubMed
    1. Feinerman O, Veiga J, Dorfman JR, Germain RN, Altan-Bonnet G. Variability and robustness in T cell activation from regulated heterogeneity in protein levels. Science. 2008;321:1081–1084.. ** This study linked variability in the activation of a clonal population of T cells to endogenous variability in the levels of two proteins, CD8 and SHP-1. The authors measured co-variation in the levels of these two proteins and using modeling, showed that this co-variation reduced the diversity of T cell response.

    1. Gascoigne KE, Taylor SS. Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs. Cancer Cell. 2008;14:111–122.. ** This paper characterized the response of 15 cell lines to three different classes of antimitotic drugs and found significant inter- as well as intra-line variation, with cells within any given cell line exhibiting multiple distinct phenotypes in response to treatment.

    1. Orth JD, Tang Y, Shi J, Loy CT, Amendt C, Wilm C, Zenke FT, Mitchison TJ. Quantitative live imaging of cancer and normal cells treated with Kinesin-5 inhibitors indicates significant differences in phenotypic responses and cell fate. Mol Cancer Ther. 2008;7:3480–3489. - PMC - PubMed
    1. Spencer SL, Gaudet S, Albeck JG, Burke JM, Sorger PK. Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis. Nature. 2009;459:428–432.. * This paper examined why, in a clonal population, some cells die after a death-inducing stimulus, while others survive indefinitely. Using time-lapse imaging, flow cytometry, and mathematical modeling, the authors showed that stochastic differences in the levels of proteins are the primary causes of cell-to-cell variability in the timing and probability of death.

Publication types

LinkOut - more resources